264 related articles for article (PubMed ID: 27082701)
1. Medication use in pregnancy and the pregnancy and lactation labeling rule.
Sahin L; Nallani SC; Tassinari MS
Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701
[TBL] [Abstract][Full Text] [Related]
2. The Importance of Clinical Research in Pregnant Women to Inform Prescription Drug Labeling.
Dinatale M; Roca C; Sahin L; Johnson T; Mulugeta LY; Fletcher EP; Yao L
J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S18-S25. PubMed ID: 33274508
[TBL] [Abstract][Full Text] [Related]
3. The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
Gruber MF
Vaccine; 2015 Nov; 33(47):6499-500. PubMed ID: 26256527
[TBL] [Abstract][Full Text] [Related]
4. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2014 Dec; 79(233):72063-103. PubMed ID: 25509060
[TBL] [Abstract][Full Text] [Related]
5. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC; King TL
J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
Beroukhim K; Abrouk M; Farahnik B
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule.
Byrne JJ; Saucedo AM; Spong CY
JAMA Netw Open; 2020 Aug; 3(8):e2015094. PubMed ID: 32865574
[TBL] [Abstract][Full Text] [Related]
8. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
Harris JB; Holmes AP; Eiland LS
Ann Pharmacother; 2021 Apr; 55(4):459-465. PubMed ID: 32885981
[TBL] [Abstract][Full Text] [Related]
9. Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs.
Fantasia HC; Harris AL
Nurs Womens Health; 2015; 19(3):266-70. PubMed ID: 26058910
[TBL] [Abstract][Full Text] [Related]
10. Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products.
Tassinari MS; Sahin L; Yao LP
Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):718-20. PubMed ID: 26223007
[TBL] [Abstract][Full Text] [Related]
11. FDA drug labeling for pregnancy and lactation drug safety monitoring systems.
Greene MF
Semin Perinatol; 2015 Nov; 39(7):520-3. PubMed ID: 26428020
[TBL] [Abstract][Full Text] [Related]
12. Drug safety: Pregnancy rating classifications and controversies.
Wilmer E; Chai S; Kroumpouzos G
Clin Dermatol; 2016; 34(3):401-9. PubMed ID: 27265079
[TBL] [Abstract][Full Text] [Related]
13. Clinicians' Perspective of the New Pregnancy and Lactation Labeling Rule (PLLR): Results from an AAAAI/FDA Survey.
Namazy J; Chambers C; Sahin L; Johnson T; Dinatale M; Lappin B; Schatz M
J Allergy Clin Immunol Pract; 2020 Jun; 8(6):1947-1952. PubMed ID: 32084595
[TBL] [Abstract][Full Text] [Related]
14. Understanding the new pregnancy and lactation drug labeling.
Watkins EJ; Archambault M
JAAPA; 2016 Feb; 29(2):50-2. PubMed ID: 26818647
[TBL] [Abstract][Full Text] [Related]
15. Changes coming to pregnancy labeling.
Traynor K
Am J Health Syst Pharm; 2015 Feb; 72(3):175-6. PubMed ID: 25596595
[No Abstract] [Full Text] [Related]
16. Clinical Lactation Studies of Neuropsychiatric Medications: Clinical Pharmacology and Labeling Considerations.
Nallani SC; Baisden K; Dinatale M; Basham L; Kwatra D; Yao L
J Clin Pharmacol; 2023 Jun; 63 Suppl 1():S159-S169. PubMed ID: 37317496
[TBL] [Abstract][Full Text] [Related]
17. Availability of Safe and Effective Therapeutic Options to Pregnant and Lactating Individuals Following the United States Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Patel A; Sushko K; Mazer-Amirshahi M; Pfuma Fletcher E; Fusch G; Chan O; Aghayi A; Chan AKC; Lacaze-Masmonteil T; Van Den Anker J; Samiee-Zafarghandy S
J Pediatr; 2023 Aug; 259():113342. PubMed ID: 36806753
[TBL] [Abstract][Full Text] [Related]
18. FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use.
Feibus KB
J Med Toxicol; 2008 Dec; 4(4):284-8. PubMed ID: 19031382
[TBL] [Abstract][Full Text] [Related]
19. Special Interest Group-Sponsored Update in Psychosomatics: Food and Drug Administration Revises Pregnancy and Lactation Drug Labeling.
Dresner N; Sachdeva J
Psychosomatics; 2016; 57(4):439-40. PubMed ID: 27283251
[No Abstract] [Full Text] [Related]
20. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]